PMID: 7540696Jun 7, 1995Paper

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors

Journal of the National Cancer Institute
J I MayordomoI García-Ribas

Abstract

Several randomized trials have tested the use of granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in relieving chemotherapy-induced bone marrow suppression. However, the use of CSFs in the treatment of neutropenic fever remains virtually unexplored. This study evaluated the benefits of adding CSF therapy to the standard antibiotic treatments given to cancer patients for chemotherapy-induced neutropenic fever. The usefulness of CSFs was quantified in terms of reducing the following: (a) the duration of neutropenia, (b) the length of hospitalization, and (c) the overall cost of the treatment. A randomized trial was conducted to test whether the administration of either G-CSF or GM-CSF improved the outcome of standard antibiotic therapy (ceftazidime plus amikacin) in nonleukemic cancer patients with fever (> 38 degrees C) and grade IV neutropenia (absolute neutrophil count [ANC] < 500/mm3) induced by standard-dose chemotherapy. Of 121 patients who entered the trial, 39 received G-CSF (5 micrograms/kg body weight per day), 39 received GM-CSF (5 micrograms/kg body weight per day), and 43 received a placebo beginning just after the first dose of antibiotics. Treatments were c...Continue Reading

Citations

Oct 19, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alison FreifeldJunfeng Sun
Nov 30, 2000·Current Infectious Disease Reports·D V Alcid, P Mathew
Nov 1, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·César Gómez RaposoManuel González Barón
Jul 14, 1999·Diagnostic Microbiology and Infectious Disease·G Maschmeyer
Oct 29, 2000·International Journal of Antimicrobial Agents·E B Rubenstein
May 1, 1997·International Journal of Antimicrobial Agents·J J RusthovenA Hamilton
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A J CroockewitH Zwierzina
Feb 19, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G H LymanL Balducci
Jan 25, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M H Mangi, A C Newland
Sep 12, 2007·Bone Marrow Transplantation·T J Littlewood, G P Collins
Feb 14, 2002·British Journal of Haematology·Thomas Lehrnbecher, Karl Welte
Jun 19, 1997·The New England Journal of Medicine·L C HartmannC G Moertel
Jan 4, 2001·Journal of the National Cancer Institute·R García-CarboneroL Paz-Ares
May 5, 1999·Current Opinion in Hematology·G H Lyman, L Balducci
Apr 16, 2002·Current Opinion in Hematology·Gary H LymanLodovico Balducci
Apr 16, 2002·Current Opinion in Hematology·Rocio Garcia-Carbonero, Luis Paz-Ares
Apr 20, 2001·Paediatric Drugs·L M Wagner, W L Furman
Dec 10, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alexandre ChanLi Yang Hsu
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Nov 9, 2001·Leukemia & Lymphoma·F BauduerUNKNOWN BGMT Collaborative Group
Sep 3, 2009·Current Medical Research and Opinion·José Ignacio MayordomoUNKNOWN ENIA Study Group
Apr 28, 2006·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Yen-Chieh WangJohnson Lin
Mar 2, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Martin ReckEnriqueta Felip
Jul 17, 2008·Supportive Cancer Therapy·Gary H Lyman, Nicole M Kuderer
Sep 27, 2003·British Journal of Haematology·Antonio PagliucaUNKNOWN Haemato-Oncology Task Force of the British Committee for Standards in Haematology
Jun 1, 1996·Infectious Disease Clinics of North America·K V RolstonA Freifeld
Dec 29, 1995·The American Journal of Medicine·F Meunier
Sep 4, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Asif Husain OsmaniBilal Ahmed
Jun 22, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Román Pérez Velasco
Jun 18, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Otavio A C ClarkBenjamin Djulbegovic
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C PatteJ Michon
Jun 10, 2003·International Journal of Cancer. Journal International Du Cancer·Simon NinckChristel Herold-Mende
Oct 31, 2014·The Cochrane Database of Systematic Reviews·Rahul MhaskarBenjamin Djulbegovic
Nov 21, 2001·Japanese Journal of Cancer Research : Gann·T HidakaS Saito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.